Evaluating the effect of immunisation with group B meningococcal vaccines on meningococcal carriage
THIS STUDY HAS NOW FINISHED
If you are a participant in this study, please see the COVID-19 update page for further information
Recruitment and clinical visits are now complete. When available, the study results will be available here
What if by getting immunised, you could help protect your friends, family and the broader community against meningitis?
Meningitis is a rare but potentially life-threatening infection around the surface of the brain. It mostly affects babies, young children and adolescents. A bacteria called meningococcus is an important cause of bacterial meningitis. About 1 in 10 teenagers ‘carry’ these bacteria at the back of their throat at any one time without causing any symptoms.
What is the ‘Be on the TEAM’ study?
This study will see if immunising teenagers with a Meningitis B (MenB) vaccine could reduce the risk of others getting meningitis across the whole community
- Teenagers who take part will receive 2 doses of a MenB vaccine
- These are licensed vaccines you would not otherwise receive and will reduce your risk of meningitis
- You would also have 2 throat swabs, 1 year apart
- Visits would be held at your school, with follow up community visits for teenagers who leave school during the study period
Click here to view the full study protocol (v7.0) (PDF)
Be on the TEAM: Teenagers against Meningitis; REC ref 18/SC/0055; IRAS 239091; OVG 2017/08; Website front page V3.0; dated 13-Oct-2020